Noradrenaline, Dopamine, Glycolysis, Adenyl Cyclase Intraventricularly injected noradrenaline, dopamine and isoprenaline increased glycolysis as shown by the decrease in the concentration of "free" glycogen and increase in the concentration of lactate.
Introduction
It is generally assumed that noradrenaline acti vates m embrane bound adenyl cyclase which brings about the intracellular synthesis of 3,5-cyclic AMP 1. Cyclic AMP then produces an appropriate physio logical response, the nature of which depends on the function of the tissue. The concentration of cyclic AMP is determ ined not only by its rate of synthesis but also by its rate of destruction by intracellular phosphodiesterases2. Therefore it is possible for drugs to influence brain glycolysis by affecting the availability of the neurohormone to adenyl cyclase, by directly affecting the activity of this enzyme or by increasing the rate of metabolism of cyclic AMP by phosphodiesterase. This study was therefore under taken using various drugs and neurohormones to manipulate the activity of the enzyme system in vivo to see what effects such changes had on brain glyco lysis.
In previous investigations into the mode of action of a num ber of /?-adrenoreceptor blocking drugs on mouse brain glycolysis, no relationship could be found between th eir peripheral /^-blocking properties and their effects on brain carbohydrate metabo lism 3-6. Indeed, propranolol appeared to be unique in its action on brain glycolysis. As part of the present study, it was therefore hoped to determine more precisely how propranolol acts.
M ethods
Specific pathogen free albino mice of the Alderley Park strain (18 -22 g, either sex) were used throughout these experiments. The mice were in jected with the drug or vehicle (control group) and the oesophageal tem peratures were determined at regular intervals during the experimental period by means of a therm istor probe (Light and Sons, B righton). If the tem perature was reduced by more than 0.5 °C the animals were kept in a constant temperature room at 38 °C until they were killed. Hypertherm ia only occurred to a slight extent after the adm inistration of caffeine.
At various times (shown in Results) after ad m inistration of the drug, groups of at least 5 mice were killed by immersion in liquid nitrogen. After thorough freezing, the mice were decapitated, their brains were rapidly chipped out, weighed and tritu rated with a protein precipitating agent (generally 1 0 % trichloracetic acid) in a cooled glass m ortar.
After centrifugation at approximately 500 x g for 10 -15 min the supernatant fraction was separated from the pellet; both fractions were kept at 0 °C until the assays were undertaken. W ith the excep tion of glycogen, the assays were perform ed on the same day as the extracts were prepared. The follow ing determinations were made.
Glycogen. The trichloracetic acid soluble (" free" ) and insoluble (" bound" ) glycogen was treated by the method described by Russel and Bloom 7 and the glucose formed after acid hydrolysis estimated by the glucose oxidase method of Hugget and Nixon 8.
Glucose and lactate were estimated by the glucose oxidase method 8 and lactic dehydrogenase methods 9 respectively, on aliquots of the supernatant fraction.
Statistical analysis of results. Results were calcu lated as ^m ol/g weight of brain. However, to com pare the effects of several different drugs on the same biochemical param eter, the results are ex pressed as percentage change relative to the control. The statistical significance was assessed using Stu dents t-test.
R esults
Effect of sodium fluoride and som e synthetic ana logues of 3,5-cyclic adenosine m onophosphate on brain glycolysis Sodium fluoride has been shown to stimulate the adenyl cyclase system of the rat pineal gland 10. This halide was therefore injected intraventricularly (50 jug in 10 [A) into groups of mice. W ithin 1 -2 sec of injection it caused hyperexcitability and on some cases clonic-tinic convulsions which lasted for 10 -20 sec. All the animals recovered but were behaviourally depressed (decreased exploration ex ploration of cages rem aining in corner of cage un less disturbed, slowed righting reflex) for the d ura tion of the experiment. Lower doses of fluoride (10 and 25 jug) had qualitatively sim ilar effects.
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Effect of Sodium Fluoride.
•p < 0 .0 5 * ' P<0.02 " *P<0.001 It is apparent from the results that sodium fluo ride increases the concentration of brain lactate and reduces that of glucose affecting the concentration of glycogen (Fig. 1 ) . The peak effect occurred 1 min after injection when the behavioural symptoms were most pronounced.
The effects of sodium fluoride were also studied in groups of animals which had been pretreated for up to 4 hours with DL-propranolol (10 m g/kg i.p .). The halide was then injected intraventricularly (50 jug) one min before the mice were killed. P ro pranolol did not appreciably affect the symptoms produced by sodium fluoride but it did antagonize most of the effects of the halide on brain lactate and glucose (F ig .2 ).
Effect of Propranolol + Sodium Fluoride. 3,5-cyclic AMP *, dibutyryl 3,5-cyclic AMP, monobutyryl 3,5-cyclic AMP and 3,5-cyclic IM P were also investigated for their effects on brain glycolysis. All were injected intraventricularly in a dose of 1 0 //g/10 //l. The behavioural effects were sim ilar; the animals were depressed for up to 8 min after in jection. However, those mice injected with 3,4-cyclic IM P were hyperactive for up to two min following injection; this was succeeded by behavioural de pression.
Mouse Brain Glycolysis in vivo
The effects of these nucleotides on brain glyco lysis were qualitatively sim ilar. All the substances increased the concentration of glycogen and lactate and decreased th at of glucose for up to 3 min fol lowing injection. These changes were followed by a reduction in lactate and increase in glucose. The effects of 3,5-cyclic AMP are shown in Fig. 3 . Quantitatively, the most marked changes in carbo hydrate metabolism were seen after the intraventricular injection of dibutyryl 3,4-cyclic AMP (Fig. 4 ) . The effect of DL-propranolol on the changes in duced by dibutyryl-3,5-cyclic AMP was also studied. In this experiment, groups of mice were treated for up to 4 hours with propranolol. Two min before being killed, and at 60, 120, 180 and 240 min after treatm ent with propranolol, the mice were injected intraventricularly with dibutyryl 3,5-cyclic AMP. Propranolol did not appreciably reduce the beha vioural changes produced by the cyclic AMP deri vative but it did significantly antagonize most of the effects this nucleotide on brain carbohydrate me tabolism (Fig. 5 ).
Previous studies (Leonard, unpublished) have shown that the maximal increase in brain glycolysis occurred 1 and 2 min respectively after the intraventricular adm inistration of 5 //g of noradrenaline or isoprenaline. In this and in all subsequent experi ments, intraventricular injections into conscious mice were made using the method of Haley and McCormick n . Groups of mice were pretreated with DL-propranolol alone (20 mg/kg i.p.) o r in combi nation with a-methyl-p-tyrosine (a-M PT ; 240 mg/kg in 4 equally divided doses over a period of 24 hours).
It is clear from the results that when the synthesis of noradrenaline is blocked by pretreatm ent of the mice with a-MPT, glycolysis is considerably reduced (Table I) . This effect of a-MPT is antagonized to some extent by the intraventricular adm inistration of noradrenaline and isoprenaline. Propranolol re duced brain lactate and increased glucose and glycogen; it antagonized the effects of both nor adrenaline and isoprenaline. It did not appreciably affect the reduction in glycolysis produced by a-MPT.
These results suggest that brain glycolysis might be controlled by an adrenergic mechanism. To in vestigate the mechanism« underlying glycolysis further it was necessary to study the effects of the precursors of noradrenaline. 
The effect of dihydroxyphenylalam ine ( d o p a ), dop a mine, diethyldithiocarbam ate and apom orphine on brain glycolysis
Dopa, when adm inistered intraperitoneally to ^ mice at a dose of 300 m g/kg, caused salivation, ■ § sweating and slight hyperexcitability in some of the £ animals. However, 60 min after injection these 8 effects had been succeeded by m arked behavioural depression and hypotherm ia. Lower doses (200, 100 and 50 mg/kg) caused only slight symptoms although hypotherm ia occurred following the ad m inistration of 200 mg/kg. The changes shown in Fig. 6 were not, however, a consequence of hypo thermia as these animals were kept at an ambient temperature of 38 °C for the duration of the ex periment.
From these results it is apparent that dopa in creases glycolysis for at least 120 min after its ad m inistration (Fig. 6 ). This is shown by the rise in lactate and fall in glucose and " bound" glycogen. There appears to be a compensatory increase in glycogenesis 120 min after the adm inistration of the drug. Dopamine was given into the lateral ventricles (10/<g in 1 0 //I of physiological saline) and the animals killed at different times for up to 30 min after injection. The same volume of physiological saline caused only slight behavioural depression which lasted for approximately 2 min. One min after dopamine however, the animals were depressed and showed occasional ear twitching. Two min later the animals were more severly depressed but hyper sensitive to touch when disturbed. They gradually recovered during the rem ainder of the experimental period.
The changes in brain carbohydrate metabolism were most marked during the first 8 min following the injection of dopam ine (Fig. 7 ) , this coincided with the period during which the behavioural changes were most m arked. There was a marked de crease in the concentration of brain glucose and glycogen and a slight rise in the concentration of lactate.
Effect of Dopamine.
Fig. 7. Effect of dopamine on mouse brain glycolysis. Dopamine injected into lateral ventricles (1 0 //g in 10,al).
Details otherwise as given in Fig. 1 .
The action of diethyldithiocarbam ate (400 mg/kg i.p.) was investigated, as this drug blocks dopamine /9-oxidase activity thereby raising endogenous brain dopamine and reducing noradrenaline levels 12. Mice injected with this drug and kept at room temperature were behaviourally depressed and hypothermic. However, at an ambient temperature of 38 °C the animals were not depressed.
The results, summarized in Fig. 8 (which were obtained from mice kept at 38 °C) show that diethyl dithiocarbam ate had an effect which was quite unlike Effect of Diethyldithiocarbamate. dopamine and dopa. This is indicated by the rise in brain glucose and "bound" glycogen and fall in lac tate. It is however, difficult to explain the marked decrease in " free" glycogen which occurs for the first 120 min after the drug was administered. As diethyldithiocarbamate is known to inhibit other enzyme systems 13,14 it is difficult to draw any firm conclusions from the present findings as to its action on brain glycolysis. There is considerable evidence to suggest that apomorphine acts directly on dopamine receptors in the central nervous system without appreciably af fecting the endogenous concentrations of the amine 15,16. This drug was therefore investigated for its effect on brain glycolysis.
The adm inistration of apom orphine (25 mg/kg i.p.) caused the mice to become very hyperexcitable, move rapidly around the cage and periodically to show stereotyped circling activity. Slight ptosis was apparent 30 min after injection. These symptoms were less marked 60 min after injection, and after 120 min most activity appeared to be confined to stereotyped "groom ing" . The mice were then beha viourally rather depressed for the rem ainder of the experimental period. No change in the oesophageal temperature was noted during the experiment. Lower doses of apomorphine (5 and 10 mg/kg) caused some hyperactivity and stereotyped behaviour but the effects were less marked.
The results of the changes in brain carbohydrate metabolism seen after apomorphine (25 mg/kg) show that this drug stimulates glycolysis as indicated by the elevated lactate and reduced glucose levels (Fig. 9 ) . Glycogen levels did not alter significantly during the experiment.
Effect of Apomorphine'.. 
D iscussion
The results of this investigation support the studies of o th e rs17,18 that noradrenaline plays an im portant role in activating the adenyl cyclase sys tem in central nervous tissue. In addition to finding that both noradrenaline and isoprenaline increase glycolysis when injected into the cerebral ventricles, the ^-adrenoceptor blocking drug DL-propranolol was found to decrease this effect of these amines. Propranolol has been shown to inhibit the activation of rat pineal gland adenyl cyclase activity by nor adrenaline in vitro 10. There is also some evidence to show that DL-propranolol reduces the in vivo con centration of brain 3,5-cyclic AMP in the grouped mice (Somerville, unpublished). The precise site of action of propranolol on the adenylcyclase system is by no means certain. However, from in vitro studies D-propranolol, which is almost devoid of /9-adrenoreceptor blocking activity, also inhibits cyclase ac tivity (Somerville, unpublished). D-Propranolol has also been shown to reduce brain glycolysis in vivo (Leonard, unpublished) and to be approximately equi-active with DL-propranolol as a local anaesthe tic a g e n t19. Thus it seems possible that propranolol reduces brain glycolysis by blocking the action of noradrenaline on central adrenergic receptors, there by reducing cyclase activity, and also by stabilising the neuronal membrane, thereby reducing nervous activity. It is also possible that the effects on the concentration of brain glucose, lactate and glycogen which were observed after the adm inistration of propranolol and a-methyl-p-tyrosine could have been influenced by changes in the uptake of glucose into the brain. Clearly this possibility will have to be studied further before more firm conclusions can be reached concerning the mechanism of action of pro pranolol on brain carbohydrate metabolism.
It was surprising to find that propranolol also antagonized the actions of intraventricularly ad ministered dibutyryl-3,5-cyclic AMP, a substance which mimics the action of 3,5-cyclic AMP as the " second" messenger in most tissues 20. Such an ef fect of propranolol might suggest that it has two sites of action in the control of brain glycolysis. One is extracellular, blocking the action of the neuro hormone, and the second is intracellular in inhibit ing the action of cyclic AMP. It is possible, however, that the relative specificity of propranolol in block ing the neurohorm one differs from that required to block the action of cyclic AMP. Other investiga tions have shown that propranolol and other ß-blockers inhibit the increase in lipolysis elicited by dibutyryl-3,5-cyclic AMP only in concentrations which probably inhibit the general metabolism of the adipose tissu e21. It is clear from ionophoretic studies that the excitation of neurones in the cere bral cortex of the cat by noradrenaline is easily and selectively antagonized by such /9-adrenoceptor blockers as propranolol, sotalol and INPEA 22. Such findings may be additional evidence for the view that the primary action of propranolol is on adenyl cyclase in the nerve cell membrane; secondary effects on the intracellular metabolism might arise when relatively high doses of the drug are given.
Besides its ability to antagonise the actions of dibutyryl-3,5-cyclic AMP, propranolol also prevents the increased glycolysis which results from the in tra ventricular adm inistration of sodium fluoride. In this respect, the action of the drug differs markedly from its effect on the response of pineal gland adenyl cyclase to fluoride ions. Thus, Weiss 10 found that propranolol had no effect while the /9-adrenergic blocking drug dichloisoprenaline actually potentiated the stimulation of adenyl cyclase activity caused by sodium fluoride. W eiss10 therefore suggested that, in the pineal gland, the cyclase systems responding to catecholamines and to sodium fluoride have may characteristics in common but that the specific site at which these compounds interact to produce their effects are different. Such a conclusion cannot be so readily drawn from the present results where pro pranolol is almost equally as effective in antagoniz ing the halide and dibutyryl-cyclic AMP induced changes in glycolysis.
It is evident from the results of other investigators that drugs which are known to specifically block a-or /^-adrenoceptors in peripheral tissues have qualitatively sim ilar effects in their actions on the brain, for example in blocking the excitatory action of noradrenaline on single neurones 22, or in block ing the activity of adenyl cyclase in the rat pineal gland 24. Recent studies have also shown that pro pranolol has a sim ilar effect to phentolamine and phenoxybenzamine on some param eters of glycolysis in the mouse brain 23. As both noradrenaline and isoprenaline are equally effective in increasing brain glycolysis, an effect which is antagonised by pro pranolol, it seems unlikely that the clear concepts of a-and /9-receptors as applied to other tissues can be applied to the brain.
Besides noradrenaline, dopamine may also have a role to play in the control of brain glycolysis. This is suggested by the finding that both dopa and dopa mine increase glycolysis and that qualitatively simi lar effects were found following the parenteral ad m inistration of apomorphine. Apomorphine has been shown by others to directly stimulate dopamine re ceptors 15,16. As it is well established that the regio nal distribution of dopamine and noradrenaline differ, it is possible that their effect on brain adenyl cyclase activity has some physiological relevance. In this respect, it is of interest that others have found little correlation between the regional distribution of noradrenaline, histamine and adenyl cyclase in brain 25.
